tiprankstipranks
pc:abkbi

ABK Biomedical

ABK Biomedical is a medical device company specializing in the research, development, and commercialization of advanced embolic therapies aimed at improving treatment outcomes for patients with benign and malignant hypervascular tumors. The company holds proprietary technology in inorganic polymer microspheres and unique delivery systems, with its Eye90 microspheres being recognized as a Breakthrough Device by the FDA. ABK Biomedical operates its own R&D and manufacturing facilities to support the development and commercialization of its innovative embolotherapy products.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$35M
Total Amount Raised$35M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$35M
Latest Funding Amount$35M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 14, 2025
Series D
$35.00M

Related News and Analysis